2022 Meeting Committees

 

Annual Meeting Chair

Alexandre Chan, Pharm.D., MPH, FCCP, FISOPP, BCPS, BCOP, APh
Founding Chair and Professor of Clinical Pharmacy
UCI School of Pharmacy & Pharmaceutical Sciences, Irvine, California, USA
Chao Family Comprehensive Cancer Center, Orange, California, USA
National Cancer Centre Singapore, Singapore

Alexandre Chan's Bio

Alexandre Chan, PharmD, MPH, BCPS, BCOP, FCCP, FISOPP, APh is a Founding Chair and Professor in Clinical Pharmacy at University of California, Irvine (UCI) School of Pharmacy & Pharmaceutical Sciences. He is also appointed as an Oncology Pharmacist at the Chao Family Comprehensive Cancer Center and a Visiting Professor at National Cancer Center Singapore. A board-certified specialist in Pharmacotherapy and Oncology Pharmacy, as well as an Advanced Practice Pharmacist in the State of California, Alex has published >210 full-length peer-reviewed manuscripts in a wide array of cancer supportive care and survivorship topics. Alex is an elected Fellow of the American College of Clinical Pharmacy and the International Society of Oncology Pharmacy Practitioners (ISOPP). He was also awarded the Steven M. Grunberg Memorial Award by MASCC in 2015. He was a past president of ISOPP, and he is appointed as the Scientific Chair for the upcoming MASCC annual meetings in 2022 and 2024.

Annual Meeting Manager

Jocelyn White, B.Comm., DES, CMP
Events & Marketing Manager, MASCC
Toronto, Canada

 

Local Organizing Committee

Martin Chasen, MBChB, FCP(SA), MPhil (Pall Med)
Associate Professor, Departments of Medicine and Community and Family Medicine, University of Toronto, Toronto, Canada
Associate Professor, Department of Family Medicine, McMaster University, Hamilton, Canada

Martin Chasen's Bio

Martin Chasen, born in Pretoria, South Africa, completed his undergraduate training at the University of Pretoria in 1983, later obtaining a specialist degree in Internal Medicine and Medical Oncology and Master of Philosophy (Palliative Medicine) at the University of Cape Town, South Africa. He is a founding member of the palliative care working group of the European Society of Medical Oncology (ESMO) and faculty member of ESMO education.

He is currently the Medical Director of Palliative Care at William Osler Health System in Brampton. He was previously the Medical Director, Palliative Care, at The Ottawa Hospital Cancer Centre and the Palliative Rehabilitation Program at Élisabeth Bruyère Ottawa.

In Montreal, Dr Chasen established the Cancer Nutrition and Rehabilitation program at McGill University and Royal Victoria Hospital.

Dr Chasen is/was the Medical lead for both Ottawa and Brampton when these sites received ESMO accreditation as a designated site for Integrated Oncology and Palliative Care.

He currently holds professorships at the Universities of Toronto, McMaster, Ottawa and McGill. He received the Elizabeth J Latimer Prize in Palliative Care from McMaster University and the Kay Blair Community Service Award, William Osler Health System.

He has in excess of 100 peer reviewed publications, abstracts and book chapters. He is the principal investigator of Canadian Institutes of Health Research MENAC (The Multimodal Exercise/Nutrition/Anti-inflammatory treatment for Cachexia) trial. Recently Dr Chasen and his team have received a CABHI (Centre for Aging and Brain Health Innovation) grant which led to a Health Canada grant of $1.4 M to further the implementation of the RELIEF app to allow patients with palliative care needs to be monitored at home. Survivorship of patients after a cancer diagnosis is a passion of his and he has initiated a fully operational clinic for patients in Brampton.

Dr Chasen has lectured internationally and nationally – and appeared on media including as invited Speaker “Palliative Care”, House of Commons, Parliament of Canada.

Dr Chasen was the Regional physician lead for Palliative Care - Champlain LHIN and is presently the Medical co-lead for the Palliative Care Network in the Central West LHIN. Under his leadership there is now a comprehensive palliative program in Central West with an inpatient acute unit, a consult service, an outpatient clinic and robust home care service as well as a virtual palliative care service.

Dr Chasen is a teacher and mentor to his peers, including being a LEAP Facilitator. He was an executive member of the CCTG Supportive Care Committee.

When Dr Chasen is not lecturing, teaching, mentoring or researching, he enjoys spending time with his beautiful wife, two daughters and two grandchildren. His enjoyment of arts and theatre is one of many of his passions.

Edward Chow, MBBS, MSc, PhD, FRCPC
Professor, Department of Radiation Oncology, University of Toronto, Toronto, Canada
Senior Scientist, Sunnybrook Research Institute, Toronto, Canada
Odette Cancer Centre, Sunnybrook Health Sciences Centre, Toronto, Canada

Edward Chow's Bio

Edward Chow is a Professor, Department of Radiation Oncology, University of Toronto and a Senior Scientist, Sunnybrook Research Institute.

Carlo DeAngelis, PharmD
Department of Pharmacy, Sunnybrook Odette Cancer Centre, Toronto, Canada
Leslie Dan Faculty of Pharmacy, University of Toronto, Toronto, Canada

Carlo DeAngelis' Bio

Carlo DeAngelis earned his Bachelor of Science in Pharmacy from the University of Toronto in 1981 and completed a Hospital Pharmacy Residency at Sunnybrook Health Sciences Centre in 1982. He graduated with a Doctor of Pharmacy from the State University of New York at Buffalo in 1984. From 1985 to 2011, Carlo was the Clinical Practice Lead for Oncology Pharmacy at Sunnybrook Odette Cancer Centre and is currently the Oncology Pharmacy Clinician Scientist at the Centre.

He is an Assistant Professor at the Leslie Dan Faculty of Pharmacy, University of Toronto where he teaches in the third year Oncology Therapeutics course. Carlo has given numerous presentations at local, national and international meetings on focused on symptom management and supportive care.

He has owned and managed a community pharmacy, Panacea Pharmacy, since 1994. This has given him unique insights into the challenges oncology patients face in the primary care environment.

His areas of research interest include the prevention and management of cancer treatment-related side effects, particularly in the elderly, and the role of pharmacists in improving outcomes of targeted anti-cancer therapies. He is working to develop a Research Program to evaluate the use of plant-derived cannabinoids for symptom management in the oncology setting. Carlo has recently started a cannabinoid consultation service at Sunnybrook Odette Cancer Centre to meet the needs of cancer patients interested in using plant-derived cannabinoids.

Lawson Eng, MD, SM, FRCPC
Medical Oncologist, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

Lawson Eng's Bio

Lawson Eng, MD, SM, FRCPC is a Medical Oncologist at the Princess Margaret Cancer Centre and incoming Assistant Professor in the Department of Medicine, University of Toronto in Toronto, Canada. His clinical practice focuses on lung, gastrointestinal and head and neck cancers. His research interests in cancer survivorship and supportive care focus on health behaviours (in particular, tobacco control) in cancer survivors, patient-reported outcomes, real-world population-level outcomes research and health services research. He serves on the Cancer Care Ontario – Smoking Cessation Research and Knowledge Translation Committee, MASCC Survivorship Study Group, and the International Association of the Study of Lung Cancer (IASLC) - Tobacco Control Committee. To date, he has published over 45 manuscripts in oncology and has over 120 abstract presentations at international meetings. He is well-recognized for his research having received multiple American Society of Clinical Oncology (ASCO) Merit Awards, Novartis Oncology Young Canadian Investigator Awards, an ASCO Young Investigator Award (2020), a MASCC Young Investigator Award (2018), the 2019 Canadian Association of Medical Oncology (CAMO) Fellowship Award and both a Canadian Institutes of Health Research (CIHR) Publication Prize and Fellowship Award. He’s been an invited speaker for multiple meetings and is serving as the Oral Abstract Session Co-Chair and Discussant for the Tobacco Control Track in the upcoming 2021 IASLC Meeting. His research has been funded by CAMO, ASCO, CIHR and the Canadian Cancer Society Research Institute.

Breffni Hannon, MB BCh BAO, BMedSci, MMedSci, MCFP
Palliative Care Site Lead, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Assistant Professor, Department of Medicine, Divisions of Palliative Medicine and Medical Oncology, University of Toronto, Toronto, Canada

Breffni Hannon's Bio

Breffni Hannon completed her specialist palliative care training in Ireland before moving to Toronto in 2011. She is a palliative care physician at the Princess Margaret Cancer Centre in Toronto, and a Clinician-Investigator in the Division of Palliative Medicine, Department of Medicine at the University of Toronto. Her research interests include early palliative care for patients with advanced cancer and their families; virtual palliative care clinics; and the routine use of patient-reported outcomes.

Samantha Mayo, RN, PhD
RBC Financial Group Chair in Oncology Nursing Research, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada
Assistant Professor Lawrence S. Bloomberg Faculty of Nursing, University of Toronto, Toronto, Canada

Samantha Mayo's Bio

Samantha Mayo, RN, PhD is an Assistant Professor at the Lawrence S. Bloomberg Faculty of Nursing, University of Toronto and holds the RBC Financial Group Chair in Oncology Nursing Research at Princess Margaret Cancer Centre in Toronto, Canada. Her research centers on optimizing the long-term health of cancer survivors by understanding patterns and predictors of late and long-term effects, investigating biological mechanisms, and designing interventions to mitigate the negative impacts of these effects, with a particular emphasis on cancer-related cognitive impairment among adults treated for blood cancers. Her research has been funded by the Canadian Blood and Marrow Transplant Group, Sigma Theta Tau International/Canadian Nurses Foundation, Canadian Association of Nurses in Oncology, Oncology Nursing Foundation, and the Canadian Institutes of Health Research. She is co-lead of the non-pharmacological intervention subgroup of the MASCC Neurological Complications Study Group and a contributing member of the Oncology Nursing Society Putting Evidence into Practice panel on Cognitive Impairment.

Deborah Saunders, BSc, DMD
Medical Director, Department Dental Oncology, North East Cancer Centre, Health Sciences North, Sudbury, Canada

Deborah Saunders' Bio

Deborah Saunders resumes a full-time practice as the Medical Director of the Department of Dental Oncology and Program Lead of the Oral Maxillofacial Rehabilitation Program at the Health Sciences North, Northeast Cancer Centre. Dr Saunders is a Certified Tobacco Educator and Regional Program Lead for the Clinical Tobacco Intervention Program at the North East Cancer Centre. She is Associate Professor at the Northern Ontario School of Medicine and Co-lead, Cancer Research, at Health Sciences North Research Institute, Sudbury Ontario. Dr Saunders is presently serving as Past President of the International Society of Oral Oncology.

David Warr, MD
Dept of Medical Oncology and Hematology (retired)
Princess Margaret Cancer Centre, University Health Network, Toronto, Canada

David Warr's Bio

Dr David Warr was the head of breast cancer medical oncology and solid tumor ward chief at the Princess Margaret Cancer Centre in Toronto, Canada, retiring in June, 2020. He is a past president of the Multinational Association of Supportive Care in Cancer and was given their distinguished service award in 2017.

His research interests in supportive care focused on antiemetics. He was the physician lead for Cancer Care Ontario antiemetic guidelines and participated in the MASCC-ESMO antiemetic guidelines.

Camilla Zimmermann, MD, PhD, FRCPC
Head and Lederman Chair, Department of Supportive Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Head, Division of Palliative Care, Princess Margaret Cancer Centre, University Health Network, Toronto, Canada
Professor of Medicine and Director, Division of Palliative Medicine, University of Toronto, Toronto, Canada

Camilla Zimmermann's Bio

Camilla Zimmermann is Head and Lederman Chair, Department of Supportive Care at the Princess Margaret Cancer Centre, Head of the Division of Palliative Care at the University Health Network, and a Senior Scientist and Chair of Supportive Care Research at the Princess Margaret Cancer Centre Research Institute in Toronto. She is also Professor of Medicine at the University of Toronto and is the inaugural Director of the Division of Palliative Medicine in the Department of Medicine at the University of Toronto.

Dr Zimmermann completed her medical and internal medicine training at McGill University, her American Board exams in Internal Medicine and in Hospice and Palliative Medicine, and a Master’s in Public Health and a PhD at the Institute of Medical Science at the University of Toronto. She is internationally known for her research on palliative and supportive cancer care, particularly in the area of early palliative care. She has published more than 200 papers in peer-reviewed journals, is co-editor of the textbook Supportive Oncology, is a member of several journal editorial boards, and is Associate Editor for BMJ Supportive and Palliative Care. She has received several research awards, including the William E. Rawls Prize by the Canadian Cancer Society. She co-chairs the Supportive Care committee of the Canadian Cancer Trials Group. Her research on early palliative care in patients with cancer is funded by the Canadian Institutes for Health Research and the Canadian Cancer Society.

For MASCC/ISOO 2022 Annual Meeting general inquiries, please contact [email protected].